Literature DB >> 11579878

Prevalence, intensity, and fertility of ovine cystic echinococcosis in the central Peruvian Andes.

E L Dueger1, R H Gilman.   

Abstract

An abattoir survey of 212 sheep of different ages was undertaken to determine the local epidemiological transmission patterns of Echinococcus granulosus in the central Peruvian Andes. Overall prevalence of the disease in sheep in this survey (which ended in July 1996) was 77.4%, with 96% of sheep aged > or = 6 years being infected. Of 1165 cysts examined, 41.1% were fertile with a mean protoscolex viability of 73.2%. A logistic regression model for the distribution of cyst fertility and type by age, location and size is described. Mathematical modelling also determined that infection pressure on sheep was 0.44 infections per year and that the mean number of cysts increased linearly by 1.28 cysts per year. These data suggest that E. granulosus is in an endemic state in this area and control measures could drive the disease towards extinction.

Entities:  

Mesh:

Year:  2001        PMID: 11579878     DOI: 10.1016/s0035-9203(01)90188-9

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  12 in total

Review 1.  Worldwide epidemiology of liver hydatidosis including the Mediterranean area.

Authors:  Giuseppe Grosso; Salvatore Gruttadauria; Antonio Biondi; Stefano Marventano; Antonio Mistretta
Journal:  World J Gastroenterol       Date:  2012-04-07       Impact factor: 5.742

2.  Viability and fertility of human hepatic hydatid cysts.

Authors:  Carlos Manterola; Manuel Vial; Angélica Melo; Carlos Oberg; Flery Fonseca
Journal:  World J Surg       Date:  2006-02       Impact factor: 3.352

3.  Autoimmunity in Human CE: Correlative with The Fertility Status of The CE Cyst.

Authors:  E A El Saftawy; A Abdelraouf; M A Elsalam; P Zakareya; A Fouad; E A Albadawi; A H S Abobakr Ali; N M Amin
Journal:  Helminthologia       Date:  2022-05-04       Impact factor: 1.176

4.  Evaluation of oxfendazole, praziquantel and albendazole against cystic echinococcosis: a randomized clinical trial in naturally infected sheep.

Authors:  Cesar M Gavidia; Armando E Gonzalez; Eduardo A Barron; Berenice Ninaquispe; Monica Llamosas; Manuela R Verastegui; Colin Robinson; Robert H Gilman
Journal:  PLoS Negl Trop Dis       Date:  2010-02-23

5.  Evaluation of nitazoxanide and oxfendazole efficacy against cystic echinococcosis in naturally infected sheep.

Authors:  Cesar M Gavidia; Armando E Gonzalez; Luis Lopera; Cesar Jayashi; Roxana Angelats; Eduardo A Barron; Berenice Ninaquispe; Lucia Villarreal; Hector H Garcia; Manuela R Verastegui; Robert H Gilman
Journal:  Am J Trop Med Hyg       Date:  2009-03       Impact factor: 2.345

Review 6.  Fact or hypothesis: concomitant immunity in taeniid cestode infections.

Authors:  M W Lightowlers
Journal:  Parasite Immunol       Date:  2010-08       Impact factor: 2.280

7.  Economic impact of cystic echinococcosis in peru.

Authors:  Pedro L Moro; Christine M Budke; Peter M Schantz; Julio Vasquez; Saul J Santivañez; Jaime Villavicencio
Journal:  PLoS Negl Trop Dis       Date:  2011-05-24

8.  Infected hydatid cysts bacteria in slaughtered livestock and their effects on protoscoleces degeneration.

Authors:  Mohammad Fallah; Abdollah Kavand; Rasoul Yousefi Mashouf
Journal:  Jundishapur J Microbiol       Date:  2014-06-01       Impact factor: 0.747

9.  Modelling the regional vulnerability to Echinococcosis based on environmental factors using fuzzy inference system: A case study of Lorestan Province, west of Iran.

Authors:  Mojtaba Ahmadinejad; Zeinab Obeidavi; Zia Obeidavi; Reza Alipoor
Journal:  Electron Physician       Date:  2017-12-25

10.  New insights of the local immune response against both fertile and infertile hydatid cysts.

Authors:  Christian Hidalgo; Caroll Stoore; Karen Strull; Carmen Franco; Felipe Corrêa; Mauricio Jiménez; Marcela Hernández; Karina Lorenzatto; Henrique B Ferreira; Norbel Galanti; Rodolfo Paredes
Journal:  PLoS One       Date:  2019-01-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.